Literature DB >> 28974468

Estimating the incidence and 30-day all-cause mortality rate of Escherichia coli bacteraemia in England by 2020/21.

A Bhattacharya1, O Nsonwu1, A P Johnson1, R Hope2.   

Abstract

Escherichia coli bacteraemia rates have been increasing in England. Using the national mandatory surveillance data for E. coli bacteraemia from 2012/13 to 2016/17, we aimed to estimate the incidence of E. coli bacteraemia and 30-day all-cause case fatality rate (CFR) by 2020/21 in the absence of new interventions to reduce infection rates. After controlling for age, sex, and hospital versus community-onset of infection, it is estimated that the incidence of E. coli bacteraemia will be 90.5 (95% PI: 89.8-91.3) per 100,000 population (N = 50,663), with an associated CFR of 11.5 (95% PI: 11.2-11.8) per 100,000 population (N = 6554), by 2020/21. Crown
Copyright © 2017. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  30-day all-cause mortality; Bacteraemia; Case-fatality rate; E. coli; England; Forecast; Incidence

Mesh:

Year:  2017        PMID: 28974468     DOI: 10.1016/j.jhin.2017.09.021

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  Urosepsis: a growing and preventable problem?

Authors:  Hannah V Thornton; Ashley Hammond; Alastair D Hay
Journal:  Br J Gen Pract       Date:  2018-10       Impact factor: 5.386

2.  Tunable Silver-Functionalized Porous Frameworks for Antibacterial Applications.

Authors:  Mark A Isaacs; Brunella Barbero; Lee J Durndell; Anthony C Hilton; Luca Olivi; Christopher M A Parlett; Karen Wilson; Adam F Lee
Journal:  Antibiotics (Basel)       Date:  2018-07-03

3.  Risk factors for community-acquired Escherichia coli bacteraemia: a systematic review protocol.

Authors:  Anna Aryee; Suvi Härmälä; Laura Shallcross; Andrew Hayward
Journal:  Wellcome Open Res       Date:  2018-09-19

4.  On the Etiological Relevance of Escherichia coli and Staphylococcus aureus in Superficial and Deep Infections - A Hypothesis-Forming, Retrospective Assessment.

Authors:  Hagen Frickmann; Andreas Hahn; Stefan Berlec; Johannes Ulrich; Moritz Jansson; Norbert Georg Schwarz; Philipp Warnke; Andreas Podbielski
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2019-10-16

5.  Realising the broader value of vaccines in the UK.

Authors:  Simon Brassel; Margherita Neri; Phill O'Neill; Lotte Steuten
Journal:  Vaccine X       Date:  2021-04-06

6.  Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.

Authors:  Elita Jauneikaite; Kate Honeyford; Oliver Blandy; Mia Mosavie; Max Pearson; Farzan A Ramzan; Matthew J Ellington; Julian Parkhill; Céire E Costelloe; Neil Woodford; Shiranee Sriskandan
Journal:  J Antimicrob Chemother       Date:  2022-05-29       Impact factor: 5.758

7.  Surviving Serum: the Escherichia coli iss Gene of Extraintestinal Pathogenic E. coli Is Required for the Synthesis of Group 4 Capsule.

Authors:  Dvora Biran; Thomas Sura; Andreas Otto; Yael Yair; Dörte Becher; Eliora Z Ron
Journal:  Infect Immun       Date:  2021-06-28       Impact factor: 3.441

Review 8.  Biocidal Resistance in Clinically Relevant Microbial Species: A Major Public Health Risk.

Authors:  Elaine Meade; Mark Anthony Slattery; Mary Garvey
Journal:  Pathogens       Date:  2021-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.